substance p (1-4) has been researched along with norfluoxetine in 1 studies
| Studies (substance p (1-4)) | Trials (substance p (1-4)) | Recent Studies (post-2010) (substance p (1-4)) | Studies (norfluoxetine) | Trials (norfluoxetine) | Recent Studies (post-2010) (norfluoxetine) |
|---|---|---|---|---|---|
| 18 | 0 | 0 | 275 | 33 | 69 |
| Protein | Taxonomy | substance p (1-4) (IC50) | norfluoxetine (IC50) |
|---|---|---|---|
| Potassium channel subfamily K member 2 | Homo sapiens (human) | 9 | |
| Sodium channel protein type 1 subunit alpha | Rattus norvegicus (Norway rat) | 0.8 | |
| Potassium voltage-gated channel subfamily C member 1 | Rattus norvegicus (Norway rat) | 0.8 | |
| Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | 2.2909 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bertilsson, L; Brodin, E; Mårtensson, B; Nyberg, S; Toresson, G | 1 |
1 other study(ies) available for substance p (1-4) and norfluoxetine
| Article | Year |
|---|---|
Fluoxetine treatment of depression. Clinical effects, drug concentrations and monoamine metabolites and N-terminally extended substance P in cerebrospinal fluid.
Topics: Adult; Aged; Depressive Disorder; Female; Fluoxetine; Glycols; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Middle Aged; Peptide Fragments; Substance P | 1989 |